DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atacand (Candesartan Cilexetil) - Adverse Event Reports - Serious Event - Dyspnoea

 



Index of reports > Cases resulting in a serious event (125) > Cases with Dyspnoea (8)

Below is the selection of adverse event reports related to Atacand (Candesartan Cilexetil) that includes cases resulting in a serious event where reactions include dyspnoea.

Adverse event in female receiving Atacand (Candesartan Cilexetil)

Reported by a physician from Brazil on 2007-06-27

Patient: female, weighing 61.0 kg (134.2 pounds)

Adverse reactions / side effects: Dyspnoea, Haemolytic Anaemia

Suspect drug(s):
Atacand (Candesartan Cilexetil)

Other drugs received by patient: Digoxin; Furosemide; Puran T4; Amaryl



Adverse event in female receiving Atacand (Candesartan Cilexetil)

Reported by a physician from Brazil on 2007-06-18

Patient: female, weighing 61.0 kg (134.2 pounds)

Adverse reactions / side effects: Dyspnoea, Haemolytic Anaemia

Suspect drug(s):
Atacand (Candesartan Cilexetil)

Other drugs received by patient: Digoxin; Furosemide; Puran T4; Amaryl



Adverse event in 70 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a physician from Brazil on 2007-06-12

Patient: 70 year old female

Adverse reactions / side effects: Dyspnoea, Haemolytic Anaemia

Suspect drug(s):
Atacand (Candesartan Cilexetil)

Other drugs received by patient: Digoxin; Furosemide



Adverse event in 78 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-05-25

Patient: 78 year old female

Adverse reactions / side effects: Dyspnoea, Pneumonia, Atrial Fibrillation, Condition Aggravated, General Physical Health Deterioration, Weight Increased, Fatigue, C-Reactive Protein Increased, Blood Creatinine Increased, Blood Glucose Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Glucophage
    Administration route: Oral
    Indication: Diabetes Mellitus
    End date: 2007-02-17

Atacand
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2007-02-05
    End date: 2007-02-17

Other drugs received by patient: Bricanyl; Pulmicort; Propavan; Impugan; Tenormin; Plendil; Simvastatin; Trombyl



Adverse event in 69 year old male receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-05

Patient: 69 year old male

Adverse reactions / side effects: Dyspnoea, Anaemia, Condition Aggravated, Thrombocytopenic Purpura, Melaena, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Cordarone
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2007-02-01
    End date: 2007-02-22

Modopar
    Administration route: Oral
    Indication: Parkinson's Disease

Ketoprofen
    Dosage: unknown
    Administration route: Oral
    Start date: 2007-02-10
    End date: 2007-02-22

Atacand
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-12-15
    End date: 2007-02-22

Lasix
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-12-15
    End date: 2007-02-22

Sinemet
    Administration route: Oral
    Indication: Parkinson's Disease

Other drugs received by patient: Stalevo 100; Requip



Adverse event in 69 year old male receiving Atacand (Candesartan Cilexetil)

Reported by a consumer/non-health professional from France on 2007-03-26

Patient: 69 year old male

Adverse reactions / side effects: Dyspnoea, Anaemia, Neutropenia, Purpura, Melaena, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Requip
    Dosage: 1tab three times per day
    Administration route: Oral
    Indication: Parkinson's Disease

Cordarone
    Dosage: 1tab per day
    Administration route: Oral
    Start date: 2007-02-01
    End date: 2007-02-22

Lasix
    Dosage: 20mg per day
    Administration route: Oral
    Start date: 2006-12-15
    End date: 2007-02-22

Modopar
    Administration route: Oral
    Indication: Parkinson's Disease

Sinemet
    Dosage: 50mg twice per day
    Administration route: Oral
    Indication: Parkinson's Disease

Ketoprofen
    Administration route: Oral
    Start date: 2007-02-10
    End date: 2007-02-22

Atacand
    Dosage: 8mg per day
    Administration route: Oral
    Start date: 2006-12-15
    End date: 2007-02-22

Stalevo 100
    Dosage: 1tab three times per day
    Administration route: Oral
    Indication: Parkinson's Disease

Other drugs received by patient: Burinex



Adverse event in 78 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-01-17

Patient: 78 year old female

Adverse reactions / side effects: Dyspnoea, Hypotension, Vertigo

Suspect drug(s):
Aldactone
    Administration route: Oral
    Indication: Cardiac Failure

Perindopril Erbumine
    Administration route: Oral
    Indication: Cardiac Failure

Atacand
    Administration route: Oral
    Indication: Cardiac Failure

Other drugs received by patient: Desloratadine; Omeprazole; Previscan



Adverse event in 78 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-01-11

Patient: 78 year old female

Adverse reactions / side effects: Right Ventricular Failure, Dyspnoea, Hypotension, Oedema Peripheral, Dizziness

Adverse event resulted in: hospitalization

Suspect drug(s):
Atacand
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-08-01

Perindopril Erbumine
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-08-01

Aldactone
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-08-01

Other drugs received by patient: Omeprazole; Desloratadine; Previscan

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009